Table 2.

Patient medications and treatments

Variable	Preimplementation (n = 70)	Postimplementation (n = 70)	p Value*
Medications associated with low bone mass
Proton pump inhibitors†	17 (24%)	17 (24%)	1.00
Thyroxin	15 (21%)	18 (26%)	0.69
Anticonvulsants‡	2 (3%)	3 (4%)	1.00
Selective serotonin reuptake inhibitors§	12 (17%)	6 (9%)	0.21
Furosemide/diuretics	18 (26%)	17 (24%)	1.00
Cyclosporin	4 (6%)	0 (0%)	0.12
Low-molecular-weight heparin	1 (1%)	1 (1%)	1.00
Tamoxifen	1 (1%)	2 (3%)	1.00
Gonadotropin-releasing hormone antagonist (luprolide)	1 (1%)	0 (0%)	1.00
Medications associated with treatment of osteoporosis
Bisphosphonate therapy	16 (23%)	16 (23%)	1.00
Calcium supplements	18 (26%)	27 (39%)	0.15
Vitamin D supplements	21 (30%)	30 (43%)	0.16

Values are expressed as number of patients, with percentage in parentheses; * p Values result from Fisher’s exact test; ^†proton pump inhibitors: omeprazole, lansoprazole, esmoprazole, and pantoprazole; ^‡anticonvulsants: phenobarbitone and phenytoin; ^§selective serotonin reuptake inhibitors: citalopram, escitalopram, fluoxetine, paroxetine, and sertraline.